Analyst Activity – Goldman Sachs Initiates Coverage On NASDAQ:ALDR – Alder BioPharmaceuticals (NASDAQ:ALDR) With a Neutral

ME Staff
-
0

Analyst Ratings For NASDAQ:ALDR – Alder BioPharmaceuticals (NASDAQ:ALDR)

Today, Goldman Sachs initiated coverage on NASDAQ:ALDR – Alder BioPharmaceuticals (NASDAQ:ALDR) with a Neutral with a price target of $17.00.

Some recent analyst ratings include

  • 4/24/2018-Goldman Sachs initiated coverage with a Neutral rating.
  • 3/28/2018-Mizuho Reiterated Rating of Buy.
  • 3/4/2018-Leerink Swann Reiterated Rating of Outperform.
  • 9/14/2017-Royal Bank of Canada initiated coverage with a Outperform rating.

Recent Insider Trading Activity For NASDAQ:ALDR – Alder BioPharmaceuticals (NASDAQ:ALDR)
NASDAQ:ALDR – Alder BioPharmaceuticals (NASDAQ:ALDR) has insider ownership of 10.60% and institutional ownership of 99.10%.

  • On 11/13/2017 Mark James Litton, Insider, sold 16,519 with an average share price of $10.80 per share and the total transaction amounting to $178,405.20.
  • On 10/16/2017 Mark James Litton, Insider, sold 16,520 with an average share price of $12.33 per share and the total transaction amounting to $203,691.60.
  • On 7/18/2017 Stephen M Dow, Director, bought 25,000 with an average share price of $10.00 per share and the total transaction amounting to $250,000.00.
  • On 6/20/2017 Jeffrey T L Smith, VP, sold 585 with an average share price of $20.00 per share and the total transaction amounting to $11,700.00.
  • On 1/18/2017 Mark James Litton, Insider, sold 1,498 with an average share price of $23.10 per share and the total transaction amounting to $34,603.80.
  • On 1/9/2017 Mark James Litton, Insider, sold 9,516 with an average share price of $23.01 per share and the total transaction amounting to $218,963.16.
  • On 12/1/2016 Jeffrey T. L. Smith, VP, sold 3,000 with an average share price of $22.78 per share and the total transaction amounting to $68,340.00.

Recent Trading Activity for NASDAQ:ALDR – Alder BioPharmaceuticals (NASDAQ:ALDR)
Shares of NASDAQ:ALDR – Alder BioPharmaceuticals closed the previous trading session at 13.75 up +0.10 0.73% with 13.649999618530273 shares trading hands.